Wetherby Asset Management Inc. lifted its stake in Danaher Co. (NYSE:DHR) by 2.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 19,234 shares of the conglomerate’s stock after buying an additional 443 shares during the period. Wetherby Asset Management Inc.’s holdings in Danaher were worth $2,748,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. CX Institutional increased its holdings in shares of Danaher by 188.7% in the first quarter. CX Institutional now owns 205 shares of the conglomerate’s stock worth $27,000 after buying an additional 134 shares during the period. Lenox Wealth Management Inc. bought a new stake in shares of Danaher in the first quarter worth about $40,000. Legacy Advisors LLC bought a new stake in shares of Danaher in the first quarter worth about $55,000. American Research & Management Co. bought a new stake in shares of Danaher in the first quarter worth about $66,000. Finally, Contravisory Investment Management Inc. bought a new stake in shares of Danaher in the second quarter worth about $69,000. Hedge funds and other institutional investors own 78.84% of the company’s stock.
Danaher stock traded down $3.31 during trading hours on Monday, hitting $135.88. 111,021 shares of the stock traded hands, compared to its average volume of 2,511,232. The business’s 50-day moving average price is $142.08. The company has a current ratio of 2.32, a quick ratio of 1.91 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $99.85 billion, a P/E ratio of 30.07, a PEG ratio of 2.51 and a beta of 0.94. Danaher Co. has a one year low of $94.59 and a one year high of $145.50.
The business also recently declared a quarterly dividend, which was paid on Friday, July 26th. Stockholders of record on Friday, June 28th were given a $0.17 dividend. The ex-dividend date was Thursday, June 27th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.50%. Danaher’s dividend payout ratio is currently 15.04%.
In other news, SVP Angela S. Lalor sold 3,091 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $132.23, for a total value of $408,722.93. Following the sale, the senior vice president now directly owns 38,515 shares of the company’s stock, valued at approximately $5,092,838.45. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CAO Robert S. Lutz sold 14,668 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $143.28, for a total value of $2,101,631.04. Following the completion of the sale, the chief accounting officer now directly owns 21,054 shares in the company, valued at $3,016,617.12. The disclosure for this sale can be found here. Over the last three months, insiders sold 392,121 shares of company stock worth $53,603,339. Insiders own 11.40% of the company’s stock.
Several research firms recently issued reports on DHR. Zacks Investment Research raised Danaher from a “sell” rating to a “hold” rating in a research note on Monday, May 6th. Janney Montgomery Scott raised their target price on Danaher from $136.00 to $174.00 and gave the stock a “buy” rating in a research note on Wednesday, April 17th. Robert W. Baird raised their target price on Danaher from $131.00 to $148.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Royal Bank of Canada set a $134.00 target price on Danaher and gave the stock a “hold” rating in a research note on Friday, July 19th. Finally, Argus raised their target price on Danaher to $165.00 and gave the stock a “buy” rating in a research note on Tuesday, July 23rd. Three analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $143.54.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Article: What is a front-end load?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.